These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 23231023)
1. Optimal use of treprostinil in pulmonary arterial hypertension: a guide to the correct use of different formulations. Skoro-Sajer N Drugs; 2012 Dec; 72(18):2351-63. PubMed ID: 23231023 [TBL] [Abstract][Full Text] [Related]
2. The role of treprostinil in the management of pulmonary hypertension. Skoro-Sajer N; Lang I Am J Cardiovasc Drugs; 2008; 8(4):213-7. PubMed ID: 18690755 [TBL] [Abstract][Full Text] [Related]
3. Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series. Enderby CY; Soukup M; Al Omari M; Zeiger T; Burger C J Clin Pharm Ther; 2014 Oct; 39(5):496-500. PubMed ID: 24806480 [TBL] [Abstract][Full Text] [Related]
4. Treprostinil for pulmonary hypertension. Skoro-Sajer N; Lang I; Naeije R Vasc Health Risk Manag; 2008; 4(3):507-13. PubMed ID: 18827901 [TBL] [Abstract][Full Text] [Related]
5. The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension. Gessler T; Seeger W; Schmehl T Ther Adv Respir Dis; 2011 Jun; 5(3):195-206. PubMed ID: 21300738 [TBL] [Abstract][Full Text] [Related]
6. Inhaled treprostinil: a therapeutic review. Channick RN; Voswinckel R; Rubin LJ Drug Des Devel Ther; 2012; 6():19-28. PubMed ID: 22291467 [TBL] [Abstract][Full Text] [Related]
7. Effectiveness and safety of inhaled treprostinil for the treatment of pulmonary arterial hypertension in children. Krishnan U; Takatsuki S; Ivy DD; Kerstein J; Calderbank M; Coleman E; Rosenzweig EB Am J Cardiol; 2012 Dec; 110(11):1704-9. PubMed ID: 22917554 [TBL] [Abstract][Full Text] [Related]
8. Treprostinil for the treatment of pulmonary arterial hypertension. Torres F; Rubin LJ Expert Rev Cardiovasc Ther; 2013 Jan; 11(1):13-25. PubMed ID: 23259441 [TBL] [Abstract][Full Text] [Related]
9. Rapid switch from intravenous epoprostenol to intravenous treprostinil in patients with pulmonary arterial hypertension. Sitbon O; Manes A; Jais X; Pallazini M; Humbert M; Presotto L; Paillette Ld; Zaccardelli D; Davis G; Jeffs R; Simonneau G; Galie N J Cardiovasc Pharmacol; 2007 Jan; 49(1):1-5. PubMed ID: 17261956 [TBL] [Abstract][Full Text] [Related]
10. Experiences with treprostinil in the treatment of pulmonary arterial hypertension. Stream AR; Bull TM Ther Adv Respir Dis; 2012 Oct; 6(5):269-76. PubMed ID: 22868690 [TBL] [Abstract][Full Text] [Related]
11. Transition From Subcutaneous or Inhaled Treprostinil to Oral Treprostinil at Home in Patients With Pulmonary Arterial Hypertension: A Retrospective Case Series. Ackerbauer KA; Tandon R J Pharm Pract; 2018 Apr; 31(2):163-166. PubMed ID: 28464760 [TBL] [Abstract][Full Text] [Related]
12. Prostacyclin for pulmonary arterial hypertension. Barnes H; Yeoh HL; Fothergill T; Burns A; Humbert M; Williams T Cochrane Database Syst Rev; 2019 May; 5(5):CD012785. PubMed ID: 31042010 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial. Jing ZC; Parikh K; Pulido T; Jerjes-Sanchez C; White RJ; Allen R; Torbicki A; Xu KF; Yehle D; Laliberte K; Arneson C; Rubin LJ Circulation; 2013 Feb; 127(5):624-33. PubMed ID: 23307827 [TBL] [Abstract][Full Text] [Related]